Clinical Trial Update: Excision of Lymph Node Trial (EXCILYNT) (Mel69) [NA]

View source ↗

Summary

This Clinical Trial Update covers the EXCILYNT (Mel69) study evaluating excision of a lymph node in melanoma. The trial is currently recruiting, with no phase i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Craig L Slingluff, Jr | Conditions: Melanoma | NA | Status: RECRUITING